Reports for SUN PHARMA CANADA INC

Company Name
SUN PHARMA CANADA INC

Shortage reports

Actual shortage:

31 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

6 (1%)

Resolved:

431 (92%)

468

Discontinuation Reports

To be discontinued:

0 (0%)

Discontinued:

41 (100%)

Reversed:

0 (0%)

41

293 (58%)

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TARO-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-12 2024-09-09 178205
TARO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-12 2024-05-09 178192
TARO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-12 2024-05-09 178195
TARO-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Resolved 2022-11-03 2024-05-09 173678
TARO-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Resolved 2022-11-16 2024-05-09 175041
TARO-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Actual shortage 2025-12-08 2025-12-08 273719
TARO-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-12 2024-05-09 178202
TARO-ZOPICLONE 7.5MG TABLET Resolved 2020-10-08 2020-12-03 125962

Showing 461 to 468 of 468

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TARO-ZOPICLONE 7.5MG TABLET Discontinued 2021-06-16 2021-06-17 141043

Showing 41 to 41 of 41